Search

Author/Creator Melanson, Maria

1. 044 Durable clinical efficacy of alemtuzumab in patients with active rrms in the absence of continuous treatment: 7-year follow-up of CARE-MS I patients (Topaz Study). Issue 6 (24th May 2018)

Authors:
McCombe, Pamela; Boyko, Alexey N; DeSeze, Jérôme; Hartung, Hans-Peter; Havrdova, Eva; Inshasi, Jihad Said; Montalban, Xavier; Pozzilli, Carlo; Selmaj, Krzysztof W; Vermersch, Patrick; Melanson, Maria; Daizadeh, Nadia; Rodriguez, Claudio E; Wijmeersch, Bart Van
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 89:Issue 6(2018)
Page Start:
A18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial. Issue 11 (21st March 2014)

Authors:
Olsson, Tomas; Boster, Aaron; Fernández, Óscar; Freedman, Mark S; Pozzilli, Carlo; Bach, Doris; Berkani, Ouali; Mueller, Markus S; Sidorenko, Tatiana; Radue, Ernst-Wilhelm; Melanson, Maria
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 85:Issue 11(2014)
Page Start:
1198
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗